JP2009526794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526794A5 JP2009526794A5 JP2008554654A JP2008554654A JP2009526794A5 JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5 JP 2008554654 A JP2008554654 A JP 2008554654A JP 2008554654 A JP2008554654 A JP 2008554654A JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- independently
- group
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 65
- 150000001875 compounds Chemical class 0.000 claims 40
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 36
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 27
- 229910052757 nitrogen Inorganic materials 0.000 claims 25
- 229910052760 oxygen Inorganic materials 0.000 claims 22
- 229910005965 SO 2 Inorganic materials 0.000 claims 19
- 229910052717 sulfur Inorganic materials 0.000 claims 19
- 125000005842 heteroatom Chemical group 0.000 claims 18
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 11
- 125000004122 cyclic group Chemical group 0.000 claims 11
- 239000001301 oxygen Substances 0.000 claims 11
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 10
- 239000011593 sulfur Substances 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 6
- -1 N (R31) Inorganic materials 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- 125000005647 linker group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 125000006574 non-aromatic ring group Chemical group 0.000 claims 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 2
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 claims 2
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 2
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 150000007854 aminals Chemical class 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 230000004129 fatty acid metabolism Effects 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- YCIPQJTZJGUXND-UHFFFAOYSA-N Aglaia odorata Alkaloid Natural products C1=CC(OC)=CC=C1C1(C(C=2C(=O)N3CCCC3=NC=22)C=3C=CC=CC=3)C2(O)C2=C(OC)C=C(OC)C=C2O1 YCIPQJTZJGUXND-UHFFFAOYSA-N 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 241000257303 Hymenoptera Species 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000000883 anti-obesity agent Substances 0.000 claims 1
- 239000003472 antidiabetic agent Substances 0.000 claims 1
- 229940125708 antidiabetic agent Drugs 0.000 claims 1
- 229940125710 antiobesity agent Drugs 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004980 cyclopropylene group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003142 primary aromatic amines Chemical class 0.000 claims 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 0 CC(C1)CN2C1CC(CC(CC1)C3C1CN(*)C3)C2 Chemical compound CC(C1)CN2C1CC(CC(CC1)C3C1CN(*)C3)C2 0.000 description 16
- MUGSKSNNEORSJG-UHFFFAOYSA-N C1C=CCOC1 Chemical compound C1C=CCOC1 MUGSKSNNEORSJG-UHFFFAOYSA-N 0.000 description 2
- NDJHJSODIHFOMT-UHFFFAOYSA-N C1NC(C2CCNCC2)NC1 Chemical compound C1NC(C2CCNCC2)NC1 NDJHJSODIHFOMT-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N C1NCCOC1 Chemical compound C1NCCOC1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- VBOVKNXVKDRXIB-UHFFFAOYSA-N C1OCC([O]2CCCCC2)=C1 Chemical compound C1OCC([O]2CCCCC2)=C1 VBOVKNXVKDRXIB-UHFFFAOYSA-N 0.000 description 2
- CRCRUNUNNSAEEN-UHFFFAOYSA-N COCC1C(CCCC2)N2CCC1 Chemical compound COCC1C(CCCC2)N2CCC1 CRCRUNUNNSAEEN-UHFFFAOYSA-N 0.000 description 2
- MBFDHESEJDXGPW-UHFFFAOYSA-N CN(C(CC1)C2)C1CC2OC Chemical compound CN(C(CC1)C2)C1CC2OC MBFDHESEJDXGPW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006007049 | 2006-02-15 | ||
| PCT/EP2007/001213 WO2007093365A2 (en) | 2006-02-15 | 2007-02-13 | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526794A JP2009526794A (ja) | 2009-07-23 |
| JP2009526794A5 true JP2009526794A5 (cg-RX-API-DMAC7.html) | 2010-04-02 |
Family
ID=38069213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554654A Pending JP2009526794A (ja) | 2006-02-15 | 2007-02-13 | 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8853208B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1987042B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009526794A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080096670A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101384605A (cg-RX-API-DMAC7.html) |
| AR (1) | AR059520A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007214710A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0707870A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2636879A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL193342A0 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200801022A (cg-RX-API-DMAC7.html) |
| UY (1) | UY30164A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007093365A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE529423T1 (de) * | 2006-05-19 | 2011-11-15 | Abbott Lab | Cns-aktivierte kondensierte bi- und heterocyclisch substituierte azabicyklische alkanderivate |
| EP2310372B1 (en) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| AU2010276441B2 (en) | 2009-07-21 | 2015-07-02 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| KR20120081123A (ko) | 2009-09-09 | 2012-07-18 | 길리애드 사이언시즈, 인코포레이티드 | 플라비비리대 바이러스의 억제제 |
| SI2523950T1 (sl) | 2010-01-15 | 2017-06-30 | Gilead Sciences, Inc. | Inhibitorji flaviviridae virusov |
| WO2011088303A1 (en) | 2010-01-15 | 2011-07-21 | Gilead Sciences , Inc. | Inhibitors of flaviviridae viruses |
| HUP1100241A3 (en) | 2011-05-06 | 2013-12-30 | Richter Gedeon Nyrt | Oxetane substituted pyrimidones |
| PT2734515E (pt) | 2011-07-13 | 2016-03-11 | Gilead Sciences Inc | Derivados de ácido tiofen-2-carboxílico úteis como inibidores de vírus flaviviridae |
| US8759544B2 (en) | 2012-08-17 | 2014-06-24 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| US8841340B2 (en) | 2012-08-17 | 2014-09-23 | Gilead Sciences, Inc. | Solid forms of an antiviral compound |
| US8927741B2 (en) | 2012-08-17 | 2015-01-06 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| BR112018012914B1 (pt) | 2015-12-22 | 2023-04-18 | SHY Therapeutics LLC | Composto, uso de um composto e composição farmacêutica |
| AU2018288841B2 (en) | 2017-06-21 | 2022-09-29 | SHY Therapeutics LLC | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease |
| WO2020132071A1 (en) | 2018-12-19 | 2020-06-25 | Shy Therapeutics. Llc | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| WO2003045306A2 (en) * | 2001-11-13 | 2003-06-05 | Emisphere Technologies, Inc. | Phenoxy amine compounds and compositions for delivering active agents |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10238865A1 (de) * | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| CA2508681A1 (en) * | 2002-12-11 | 2004-06-24 | 7Tm Pharma A/S | Quinoline compounds for use in mch receptor related disorders |
| DE10306250A1 (de) * | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU2004285913A1 (en) * | 2003-10-23 | 2005-05-12 | Glaxo Group Limited | 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety |
| CA2558272C (en) * | 2004-03-05 | 2011-02-15 | Banyu Pharmaceutical Co., Ltd. | Pyridone derivative |
| US20050256124A1 (en) * | 2004-04-15 | 2005-11-17 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
-
2007
- 2007-02-13 EP EP07711519.4A patent/EP1987042B1/en not_active Not-in-force
- 2007-02-13 WO PCT/EP2007/001213 patent/WO2007093365A2/en not_active Ceased
- 2007-02-13 CN CNA2007800056310A patent/CN101384605A/zh active Pending
- 2007-02-13 AU AU2007214710A patent/AU2007214710A1/en not_active Abandoned
- 2007-02-13 CA CA002636879A patent/CA2636879A1/en not_active Abandoned
- 2007-02-13 KR KR1020087020095A patent/KR20080096670A/ko not_active Withdrawn
- 2007-02-13 BR BRPI0707870-6A patent/BRPI0707870A2/pt not_active IP Right Cessation
- 2007-02-13 JP JP2008554654A patent/JP2009526794A/ja active Pending
- 2007-02-13 TW TW096105357A patent/TW200801022A/zh unknown
- 2007-02-15 UY UY30164A patent/UY30164A1/es unknown
- 2007-02-15 AR ARP070100659A patent/AR059520A1/es not_active Application Discontinuation
-
2008
- 2008-08-10 IL IL193342A patent/IL193342A0/en unknown
- 2008-08-14 US US12/191,678 patent/US8853208B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009526794A5 (cg-RX-API-DMAC7.html) | ||
| JP2009526792A5 (cg-RX-API-DMAC7.html) | ||
| JP2009526793A5 (cg-RX-API-DMAC7.html) | ||
| JP2009526795A5 (cg-RX-API-DMAC7.html) | ||
| RU2008136898A (ru) | Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств | |
| US8461191B2 (en) | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | |
| TW536401B (en) | A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain | |
| KR101605151B1 (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| BR112020014160A2 (pt) | Compostos de benzamida | |
| ES2573715T3 (es) | Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia | |
| BR112013013950A2 (pt) | antagonista de lpa1 policíclico e usos dos mesmos | |
| WO2011159550A3 (en) | Lysophosphatidic acid receptor antagonist and uses thereof | |
| CO6270360A2 (es) | Antagonistas no basicos del receptor de la hormona concentradora de melanina 1 y procedimientos | |
| JP2006501202A5 (cg-RX-API-DMAC7.html) | ||
| RU2624446C2 (ru) | Трициклические соединения, композиции, содержащие указанные соединения, и их применения | |
| CN104487429A (zh) | 杂环黄酮衍生物、组合物及与其相关的方法 | |
| JP2012523395A5 (cg-RX-API-DMAC7.html) | ||
| BR112020010429A2 (pt) | uso de agonista de kor em combinação com agonista de mor na preparação de fármaco para tratamento da dor | |
| RU2011145054A (ru) | Кристаллические формы саксаглиптина | |
| RU2009135016A (ru) | Твердые формы, содержащие (-)-о-десметилвенлафаксин, и их применения | |
| BRPI0519287A2 (pt) | derivados de amida | |
| ES2820511T3 (es) | Ureas asimétricas p-sustituidas y usos médicos de las mismas | |
| CO6430439A2 (es) | Agonistas del receptor de esfingosina -1- fosfato | |
| JP2023500857A (ja) | 新規な化合物およびそれを含むがんの予防または治療用薬学組成物 | |
| JP2005533784A (ja) | 吐き気および嘔吐の治療のためのネフォパムの使用 |